US Broker Ratings

Nyxoah SA (NYXH) Stock Analysis: A Healthcare Innovator with 116% Potential Upside

For investors seeking opportunities in the healthcare sector, Nyxoah SA (NASDAQ: NYXH) presents an intriguing prospect. As a Belgian-based medical technology company specializing in solutions for obstructive sleep apnea (OSA),..

XOMA Royalty Corporation (XOMA): Unpacking the 85.5% Potential Upside Amidst Biotech Innovation

XOMA Royalty Corporation (NASDAQ: XOMA) is capturing investor attention with its compelling 85.5% potential upside, as reflected in recent analyst target price ranges. As a unique player in the healthcare..

Tvardi Therapeutics, Inc. (TVRD) Stock Analysis: Navigating a 98.69% Potential Upside in the Biotechnology Sector

Tvardi Therapeutics, Inc. (NASDAQ: TVRD) is capturing the attention of investors with its robust potential upside of 98.69%, positioning itself as a promising contender in the biotechnology sector. The clinical-stage..

Marti Technologies, Inc. (MRT) Stock Analysis: 115% Potential Upside Ignites Investor Interest

Marti Technologies, Inc. (NASDAQ: MRT) is a rising player in the tech-enabled urban transportation sector, headquartered in the vibrant city of Istanbul, Turkey. Specializing in software applications within the technology..

Nano-X Imaging Ltd (NNOX) Stock Analysis: Exploring a Promising 106.67% Upside Potential in the Medical Device Sector

In the ever-evolving landscape of medical technology, Nano-X Imaging Ltd (NASDAQ: NNOX) stands out as a disruptive force within the healthcare sector. Specializing in innovative imaging solutions, this Israeli-based company..

Senseonics Holdings, Inc. (SENS) Stock Analysis: Exploring a 216% Potential Upside in the Medical Device Sector

Senseonics Holdings, Inc. (NYSE: SENS), a key player in the healthcare sector, is making waves in the medical device industry with its innovative continuous glucose monitoring (CGM) systems. Headquartered in..

Aurora Cannabis Inc. (ACB) Stock Analysis: Exploring a 28.65% Potential Upside for Investors

Aurora Cannabis Inc. (NASDAQ: ACB) stands as a prominent player within the healthcare sector, specifically in the drug manufacturing industry, specializing in both specialty and generic cannabis products. Based in..

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Is a 247.74% Upside Within Reach for Investors?

As investors navigate the volatile biotechnology sector, Entrada Therapeutics, Inc. (NASDAQ: TRDA) presents a particularly intriguing opportunity. With a market capitalization of $202.36 million, this Boston-based biotech firm is making..

Benitec Biopharma Inc. (BNTC) Stock Analysis: An 84.86% Upside Potential Beckons Investors

Benitec Biopharma Inc. (NASDAQ: BNTC), a clinical-stage biotechnology company, is capturing investor attention with a standout potential upside of 84.86%. Positioned in the healthcare sector, this Hayward, California-based entity is..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Exploring a Biotech Gem with Potential 306.57% Upside

In the realm of biotechnology, few companies capture investor attention as dynamically as Arcturus Therapeutics Holdings (NASDAQ: ARCT). This San Diego-based firm is making waves in the healthcare sector with..

Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: Exploring a 69.81% Potential Upside in the Biotechnology Space

Fulcrum Therapeutics, Inc. (NASDAQ: FULC), a burgeoning name in the biotechnology sector, has been garnering attention for its innovative approach to treating genetically defined diseases. Headquartered in Cambridge, Massachusetts, Fulcrum..

Harrow, Inc. (HROW) Stock Analysis: Evaluating Robust Growth with 54.10% Upside Potential

Harrow, Inc. (NASDAQ: HROW) is capturing the attention of investors in the healthcare sector, particularly within the niche of ophthalmic pharmaceuticals. With a market capitalization of $1.44 billion, Harrow, Inc...

Integra LifeSciences Holdings C (IART) Stock Analysis: Insights Into Its 4.92% Potential Upside

Integra LifeSciences Holdings C (IART) is a noteworthy player in the healthcare sector, specifically within the medical devices industry. The company, headquartered in Princeton, New Jersey, has carved a niche..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 138% Potential Upside in Biotechnology

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is drawing significant attention in the biotechnology sector, not only for its innovative approach to tackling diseases driven by dysregulated aldosterone but also for its..

Mesoblast Limited (MESO) Stock Analysis: Unveiling a 95% Potential Upside in the Biotech Sector

Mesoblast Limited (NASDAQ: MESO) is capturing the attention of investors with its promising regenerative medicine platform and a significant potential upside of 95.23%. Specializing in groundbreaking treatments for severe inflammatory..

Aurinia Pharmaceuticals (AUPH) Stock Analysis: Navigating a 22.4% Revenue Growth Amidst a Competitive Biotech Landscape

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a key player in the biotechnology sector, continues to capture investor attention with its promising growth trajectory and innovative therapeutic solutions. Headquartered in Edmonton, Canada,..

The Pennant Group, Inc. (PNTG) Stock Analysis: Unpacking a 39.94% Potential Upside

Investors with an eye on the healthcare sector might find The Pennant Group, Inc. (NASDAQ: PNTG) an intriguing prospect. Headquartered in Eagle, Idaho, Pennant operates within the Medical Care Facilities..

10x Genomics, Inc. (TXG) Stock Analysis: Assessing the 7.62% Potential Upside for Investors

10x Genomics, Inc. (NASDAQ: TXG) stands at the forefront of innovation within the healthcare sector, specifically in the health information services industry. Founded in 2012 and headquartered in Pleasanton, California,..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring a Potential 37% Upside for Investors

Astrana Health Inc. (ASTH) is making waves in the healthcare sector with promising growth prospects and a solid market position. With a current market capitalization of $1.48 billion, this Alhambra,..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a 41.57% Potential Upside in the Healthcare Sector

Pulse Biosciences, Inc. (NASDAQ: PLSE) is making waves in the healthcare sector with its innovative bioelectric medicine solutions. Operating primarily in the medical instruments and supplies industry, the company has..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds